Scientists suggest a new tactic for starving tumors
                 Source: Xinhua | 2018-06-26 03:31:23 | Editor: huaxia

In this tumor, imaged in a mouse model of breast cancer, oxygen-low areas appear in green. These regions tend to resist standard cancer treatments. (Credit: Laboratory of Metabolic Regulation and Genetics at The Rockefeller University)

WASHINGTON, June 25 (Xinhua) -- American researchers found a potential new tactic against cancer: starving tumors by depriving them of a crucial protein they must utilize.

A study published on Monday in the journal Nature Cell Biology revealed that some ever-dividing tumor cells struggled to make enough aspartate with limited oxygen supply, possibly lending a target for cancer treatment.

Scientists from the Rockefeller University already knew that when certain tumors had outgrown their blood supply, they grew slowly under low-oxygen conditions. The oxygen molecule would participate in a vast number of a cell's chemical reactions, any of which could be limiting its growth.

They mimicked oxygen deprivation in cancer cells harvested from 28 patients, including cancers from blood, stomach, breast, colon and lung, which they cultured in the lab.

Many of these cells exhibited stunted growth under low-oxygen-like conditions. In the sensitive cells, a lack of aspartate would affect not only the production of new proteins, but also several other processes that rely on aspartate, such as the synthesis of genetic material, according to the study.

However, there's other tumors that were less sensitive, and some weren't bothered at all by the treatment.

In comparing these cells' production of chemicals, or metabolites, Javier Garcia-Bermudez, a postdoctoral associate at the university, noticed that the most sensitive ones lost the amino acid aspartate under oxygen deprivation.

Cells can't make aspartate without oxygen, but it seemed as if the resistant cells were able to obtain it from their environment, according to Garcia-Bermudez.

The researchers found there was something special about many of the cancers that resisted oxygen deprivation: they turned on a gene called SLC1A3 to suck up aspartate from their surroundings.

When Garcia-Bermudez turned on this gene in the lab-grown cancers that were normally sensitive to low oxygen, they grew faster.

The discovery might offer opportunities for creating drugs to stab cancers in this particular Achilles' heel, making them even hungrier for aspartate.

There might be several ways to prevent cancer cells from getting aspartate by blocking their methods to make the amino acid or take it up from their surroundings, according to the researchers.

If they are right, an anti-aspartate treatment might one day provide a supplement to typical chemotherapy and radiation, and it could potentially be effective for any type of tumor containing oxygen-starved areas.

Kivanc Birsoy, head of the Laboratory of Metabolic Regulation and Genetics at the university, envisioned a sort of one-two punch: One treatment for the parts of a tumor that are well-supplied with oxygen, and an aspartate blocker for the rest.

That sort of drug combination is still a long ways off, however. Birsoy now planned to investigate possible drugs that would interfere with aspartate production in the lab.

Back to Top Close
Xinhuanet

Scientists suggest a new tactic for starving tumors

Source: Xinhua 2018-06-26 03:31:23

In this tumor, imaged in a mouse model of breast cancer, oxygen-low areas appear in green. These regions tend to resist standard cancer treatments. (Credit: Laboratory of Metabolic Regulation and Genetics at The Rockefeller University)

WASHINGTON, June 25 (Xinhua) -- American researchers found a potential new tactic against cancer: starving tumors by depriving them of a crucial protein they must utilize.

A study published on Monday in the journal Nature Cell Biology revealed that some ever-dividing tumor cells struggled to make enough aspartate with limited oxygen supply, possibly lending a target for cancer treatment.

Scientists from the Rockefeller University already knew that when certain tumors had outgrown their blood supply, they grew slowly under low-oxygen conditions. The oxygen molecule would participate in a vast number of a cell's chemical reactions, any of which could be limiting its growth.

They mimicked oxygen deprivation in cancer cells harvested from 28 patients, including cancers from blood, stomach, breast, colon and lung, which they cultured in the lab.

Many of these cells exhibited stunted growth under low-oxygen-like conditions. In the sensitive cells, a lack of aspartate would affect not only the production of new proteins, but also several other processes that rely on aspartate, such as the synthesis of genetic material, according to the study.

However, there's other tumors that were less sensitive, and some weren't bothered at all by the treatment.

In comparing these cells' production of chemicals, or metabolites, Javier Garcia-Bermudez, a postdoctoral associate at the university, noticed that the most sensitive ones lost the amino acid aspartate under oxygen deprivation.

Cells can't make aspartate without oxygen, but it seemed as if the resistant cells were able to obtain it from their environment, according to Garcia-Bermudez.

The researchers found there was something special about many of the cancers that resisted oxygen deprivation: they turned on a gene called SLC1A3 to suck up aspartate from their surroundings.

When Garcia-Bermudez turned on this gene in the lab-grown cancers that were normally sensitive to low oxygen, they grew faster.

The discovery might offer opportunities for creating drugs to stab cancers in this particular Achilles' heel, making them even hungrier for aspartate.

There might be several ways to prevent cancer cells from getting aspartate by blocking their methods to make the amino acid or take it up from their surroundings, according to the researchers.

If they are right, an anti-aspartate treatment might one day provide a supplement to typical chemotherapy and radiation, and it could potentially be effective for any type of tumor containing oxygen-starved areas.

Kivanc Birsoy, head of the Laboratory of Metabolic Regulation and Genetics at the university, envisioned a sort of one-two punch: One treatment for the parts of a tumor that are well-supplied with oxygen, and an aspartate blocker for the rest.

That sort of drug combination is still a long ways off, however. Birsoy now planned to investigate possible drugs that would interfere with aspartate production in the lab.

010020070750000000000000011105091372803221
一分pk10 大发app 凤凰彩票app 乐发iv游戏平台 凤凰彩票大厅 乐发彩票 乐发彩票app下载 大发彩票 乐发v官网 乐发lll 乐发lv入口 乐发iv首页 乐发ll登录 凤凰彩票大厅 乐发官网 乐发ii下载入口 乐发ll 乐发v平台 乐发v官网 乐发lll 乐发lv入口 乐发iv首页 乐发ll登录 乐发lv 乐发lll安装 乐发lv 乐发登录入口 乐发iv游戏平台 凤凰彩票登录 网信彩票 彩神 彩神彩票官方网站 彩神彩票官网首页 彩神官方app下载安卓版 凤凰彩票登录 彩神v3 凤凰彩票app下载 彩神官方app下载安卓版 网信快三 一分快3 快三彩票购彩平台 凤凰彩票官方 快3官网 网信彩票 快3app 网信彩票平台 百姓彩票平台 网信平台官网 快3app下载 百姓彩票 每日彩票 快3app 百姓彩票 每日彩票 快3app 百姓彩票平台 幸运5分彩快3 快3彩票app下载 百姓彩票网站网址 大发10分PK10 快3下载 网信彩票平台 网信平台官网 快3彩票官网app 凤凰彩票官方 彩神彩票 大发10分PK10 彩神v3 大发彩票app下载 百姓彩票网站网址 彩神购彩平台 每日彩票 官方正规快三彩票平台 彩神彩票购彩平台 百姓彩票 凤凰彩票购彩平台 凤凰彩票app下载 彩神官方app下载安卓版 网信快三 一分快3 快三彩票购彩平台 凤凰彩票官方 彩神彩票 大发10分PK10 彩神v3 凤凰彩票登录 乐发lv 乐发∨Il 百姓彩票网站网址 乐发彩票 乐发彩票官方网站 乐发lll安装 百姓彩票网站网址 凤凰彩票app下载 大发10分PK10 乐发2 乐发app 凤凰彩票 大发彩票app 乐发登录入口 乐发ll登录 乐发v官网 乐发官网 大发彩票app下载 凤凰彩票购彩平台 彩神彩票 官方正规快三彩票平台 一分快3 百姓彩票网站网址 凤凰彩票app下载 大发10分PK10 乐发2 乐发app 凤凰彩票 大发彩票app 乐发登录入口 乐发ll登录 乐发v官网 乐发官网 大发彩票app下载 凤凰彩票购彩平台 彩神彩票 官方正规快三彩票平台 1分快三平台 百姓彩票平台 凤凰彩票登录 幸运5分彩快3 彩神 乐发彩票 乐发 大发彩票 乐发iv游戏平台 乐发lv 乐发lll 乐发ii下载入口 乐发彩票官方网站 凤凰彩票官方网站 凤凰快3 彩神彩票官网首页 1分快三平台 百姓彩票平台 凤凰彩票登录 幸运5分彩快3 彩神 乐发彩票 乐发 大发彩票 乐发iv游戏平台 乐发lv 凤凰彩票app 乐发app 网信彩票平台 网信彩票平台 乐发iv游戏平台 凤凰彩票app 乐发lv 乐发彩票app下载 凤凰彩票app 网信彩票平台 乐发彩票app下载 乐发lv 乐发app 大发彩票安卓下载 大发彩票安卓下载 大发彩票 乐发彩票app下载 网信彩票平台 乐发iv游戏平台 彩神彩票 乐发彩票中心 极速快3彩票平台 人人快三凤凰 大发彩票app 大发彩票大全 乐发彩票 彩神彩票官方网站 乐发app 酷天堂彩票平台 凤凰彩票app下载 凤凰彩票大厅 凤凰彩票app 极速快3彩票平台 凤凰彩票 凤凰快3 乐发ll官网 乐发彩票中心 正规快三送彩金平台 凤凰彩票官方 乐发ll 乐发 网信彩票 彩神彩票 彩神彩票官方网站 大发彩票app 网信彩票用户 百姓快三 百姓彩票平台 乐发lv 乐发彩票app下载 彩信平台 网信彩票 乐发彩票官方网站 乐发∨Il 人人快三凤凰 凤凰彩票 凤凰快3 乐发ll官网 乐发彩票中心 正规快三送彩金平台 凤凰彩票官方 乐发ll 乐发 网信彩票 彩神彩票 彩神彩票官方网站 人人快三凤凰 乐发彩票 彩神彩票 乐发iv游戏平台 乐发彩票 大发彩票中心 凤凰彩票登录 凤凰彩票app 彩神彩票 大发彩票 乐发ll 大发彩票app 凤凰快3 凤凰彩票 彩神彩票 乐发ll 凤凰彩票 乐发lll 凤凰彩票大厅 网信彩票 彩神彩票 乐发lv 快盈彩票 乐发彩票官方网站 盈彩网投资平台 大发官网 一分时时彩 乐发lv 快3平台 凤凰快3 乐发ll 全民彩票 乐发彩票官方网站 百姓彩票 乐发彩票 大发彩票 极速快3 乐发app 大发官网 乐发lll 快3平台 凤凰快3 乐发ll 全民彩票 乐发彩票官方网站 百姓彩票 乐发彩票 大发彩票 极速快3 乐发app 彩神iv 大发彩票app 大小单双平台 一分pk10 乐发lv 快盈彩票 乐发官网 快彩彩票 百姓彩票 凤凰彩票大厅 网信彩票 乐发彩票中心 网信快3 乐发 彩神xl 三分快3 大发彩票 大发官网 乐发lll 快3平台 凤凰快3 乐发ll 全民彩票 乐发彩票官方网站 百姓彩票 乐发彩票 乐发彩票官方网站 大发彩票 乐发 分分快3 彩神vl 55世纪 55世纪 凤凰快3 乐发彩票 乐发lv welcome凤凰彩票 乐发ll 1分快3 彩神 彩神ll 1分快3官网 1分快3的平台 welcome凤凰彩票 三分快3 彩神x 彩神vl 凤凰彩票 彩神xl 大发彩票 凤凰彩票大厅 乐发官网 乐发ll 乐发lll 乐发lv 大发彩票app 大发彩票 乐发 乐发彩票 乐发彩票中心 凤凰快3 乐发彩票 彩神xl 腾讯快3 大发彩票 彩神xl 大发彩票 乐发彩票 大发彩票app 快3平台 乐发 1分快3 乐发彩票 彩神x 凤凰快3 彩神xl 彩吧助手 大发彩票app 快3平台 大发排列3 彩神iv 彩神vl 乐发IV 彩神x 一分pk10 大发排列3 乐发lv 快3彩票 乐发app下载 三分快3 快三平台助手 乐发彩票ll 彩神iv 乐发lll下载 盈彩网投资平台 乐发Ⅲ 一分pk10 凤凰彩票 乐发Vll 大发官网 乐发ll 大发彩票 乐发1 凤凰快3 彩神vl 乐发lx 百姓彩票 乐发VI 彩神x 乐发IV 极速快3 乐发 凤凰快3 网信快3 乐发lv 快3彩票 乐发app下载 三分快3 快三平台助手 乐发彩票ll 彩神iv 乐发lll下载 盈彩网投资平台 乐发Ⅲ 凤凰彩票大厅 乐发lv 乐发lv 乐发lv 凤凰彩票 大发彩票 大发彩票 凤凰彩票 乐发lv 凤凰彩票 凤凰彩票 乐发lv 乐发ll 凤凰彩票app下载 凤凰彩票 凤凰彩票 乐发lv 乐发ll 凤凰彩票app下载 凤凰彩票 凤凰彩票 乐发lv 彩神x 乐发 乐发ll 极速快3 乐发lv 乐发彩票中心 快3彩票 凤凰彩票大厅 彩神x 凤凰彩票app 分分快3 网信彩票 网盟彩票 凤凰彩票 百姓彩票 乐发 快彩彩票 乐发彩票 快3平台 百姓彩票 大小单双平台 凤凰快3 彩神xl 一分pk10 乐发lv 三分快3 大发彩票 乐发彩票 快3平台 百姓彩票 大小单双平台 凤凰快3 彩神xl 一分pk10 乐发lv 三分快3 大发彩票 极速快3 乐发ll 网信彩票 乐发lv 全民彩票 凤凰彩票app下载 快盈彩票 大发彩票app 大发官网 凤凰彩票 彩神iv 大发彩票 网信快3 凤凰彩票 百姓彩票